• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer.

作者信息

Ahmann D L, Bisel H F, Eagan R T, Edmonson J H, Hahn R G

出版信息

Cancer Chemother Rep. 1974 Nov-Dec;58(6):877-82.

PMID:4614896
Abstract
摘要

相似文献

1
Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer.
Cancer Chemother Rep. 1974 Nov-Dec;58(6):877-82.
2
Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.阿霉素对耐环磷酰胺、甲氨蝶呤、5-氟尿嘧啶、长春新碱和泼尼松联合方案的转移性乳腺癌的活性。
Cancer Treat Rep. 1978 Mar;62(3):449-50.
3
Combination chemotherapy with adriamycin (NSC-123127) in metastatic mammary carcinoma.
Cancer Chemother Rep. 1974 Mar-Apr;58(2):251-3.
4
Adriamycin (NSC-123127) in combination with cyclophosphamide (NSC-26271): a phase I and II evaluation.
Cancer Chemother Rep. 1974 Nov-Dec;58(6):919-26.
5
A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project.环磷酰胺、阿霉素、5-氟尿嘧啶（CAF）与环磷酰胺、甲氨蝶呤、5-氟尿嘧啶、长春新碱、泼尼松（CMFVP）治疗转移性乳腺癌患者的比较：一项东南癌症研究组项目
Cancer. 1977 Aug;40(2):625-32. doi: 10.1002/1097-0142(197708)40:2<625::aid-cncr2820400206>3.0.co;2-m.
6
Combination chemotherapy for disseminated carcinoma of the breast.
Bol Asoc Med P R. 1975 Jun;67(6):157-63.
7
A phase 2 evaluation of 1-(2-chloroethyl)-3-(4- methylcyclohexyl)-1-nitrosourea (NSC 95441) in patients with advanced breast cancer.
Cancer Res. 1974 Jan;34(1):27-30.
8
Evaluation of single-drug versus multiple-drug chemotherapy in the treatment of advanced breast cancer.
Cancer Treat Rep. 1977 Jan-Feb;61(1):47-50.
9
An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
Surg Gynecol Obstet. 1974 Jan;138(1):77-80.
10
Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer.
Cancer Chemother Rep. 1974 Nov-Dec;58(6):861-5.

引用本文的文献

1
The Impact of Adding Taxanes to Anthracyclines on Women with Breast Cancer Receiving Adjuvant Chemotherapy.在接受辅助化疗的乳腺癌女性中，将紫杉烷类药物添加到蒽环类药物中的影响。
Cureus. 2020 Feb 27;12(2):e7117. doi: 10.7759/cureus.7117.
2
Adjuvant chemotherapy in breast cancer: To use or not to use, the anthracyclines.乳腺癌的辅助化疗：使用还是不使用蒽环类药物。
World J Clin Oncol. 2014 Aug 10;5(3):529-38. doi: 10.5306/wjco.v5.i3.529.
3
Addition of drug/s to a chemotherapy regimen for metastatic breast cancer.在转移性乳腺癌化疗方案中添加药物。
Cochrane Database Syst Rev. 2010 Nov 10;2010(11):CD003368. doi: 10.1002/14651858.CD003368.pub3.
4
Single agent versus combination chemotherapy for metastatic breast cancer.转移性乳腺癌的单药化疗与联合化疗
Cochrane Database Syst Rev. 2009 Apr 15;2009(2):CD003372. doi: 10.1002/14651858.CD003372.pub3.
5
Antitumour antibiotic containing regimens for metastatic breast cancer.用于转移性乳腺癌的含抗肿瘤抗生素方案。
Cochrane Database Syst Rev. 2004 Oct 18;2004(4):CD003367. doi: 10.1002/14651858.CD003367.pub2.
6
Heat shock proteins and drug resistance.
Breast Cancer Res Treat. 1994;32(1):67-71. doi: 10.1007/BF00666207.
7
Adriamycin and VP16-213 combination treatment for breast cancer previously treated by the CMF regimen.
Cancer Chemother Pharmacol. 1982;7(2-3):231-3. doi: 10.1007/BF00254557.
8
Chemotherapy of breast cancer.乳腺癌的化疗
Med Oncol Tumor Pharmacother. 1984;1(3):169-92. doi: 10.1007/BF02934139.
9
Weekly low dose doxorubicin monotherapy in metastatic breast cancer resistant to previous hormonal and cytostatic treatment.每周低剂量阿霉素单药治疗对先前激素和细胞抑制治疗耐药的转移性乳腺癌。
Breast Cancer Res Treat. 1985;6(1):89-93. doi: 10.1007/BF01806014.
10
Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European study.米托蒽醌作为晚期乳腺癌一线化疗药物：一项欧洲合作研究的结果
Invest New Drugs. 1985;3(2):139-48. doi: 10.1007/BF00174161.